NEOMEDLIGHT SAS of Villeurbanne at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair
Manufacturers

NEOMEDLIGHT SAS

88-90 rue Frédéric Fays, 69100 Villeurbanne
France

Telephone +33 9 72482619
bene@neomedlight.com

This company is co-exhibitor of
Business France

Hall map

MEDICA 2017 hall map (Hall 17): stand A24

Fairground map

MEDICA 2017 fairground map: Hall 17

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.09  Hospital and Care equipment
  • 01.09.05  Neonatal care equipment

Our products

Product category: Neonatal care equipment

NEONATAL JAUNDICE

Jaundice, also known as icterus, is a yellow pigmentation of the skin which is caused by high blood bilirubin levels (i.e. hyperbilirubinemia). Bilirubin is a natural yellow pigment produce by the breakdown from the red blood cells. Bilirubin circulates in the blood in the unconjugated form, which is then conjugated in the liver. The conjugation allows the transformation of a water-insoluble molecule in a water-soluble one, from unconjugated bilirubin to conjugated bilirubin, which can then be excreted in the bile.

Hyperbilirubinemia is a frequent disease after birth and occurs in 60 to 70% of term newborns and nearly all of preterm ones. Neonatal hyperbilirubinemia occurs in neonates because there is an imbalance between increased production and decreased elimination of bilirubin related to a temporarily impaired conjugation system of the liver.
The goal of the therapy is to decrease the level of the circulating unconjugated bilirubin or at least keeping it from increasing. Light in the range of approximately 400 to 500 nm with a peak at 460 nm is considered the most effective and is the standard treatment for neonatal Hyperbilirubinemia.
The interaction of blue light with bilirubin causes a photochemical change which transform unconjugated bilirubin into a water-soluble product that can be eliminated without the liver conjugation step.

Level of Bilirubin must be monitored as uncontrolled level of bilirubin can have severe consequences due to the toxicity of the bilirubin to brain (brainstem and basal ganglion); it can cause Kernicterus, or bilirubin encephalopathy, leading to devastating and permanent brain damages.

More Less

Product category: Neonatal care equipment

BiliCocoon® Nest System

The BiliCocoon® Nest system is more adapted for preterm babies

Efficacy: Large pad allowing wrapping

Safety: Easy access to the newborn

Cocooning: Adapted for kangaroo care and incubator

More Less

Product category: Neonatal care equipment

Bag System

The BiliCocoon® Bag System is more adapted for term babies.

Efficacy: Light emitted to front and back, 360° exposure.

Safety: Little light escaping the bag.
Nc-DSnaL414
Cocooning: Handling, cuddling, breastfeeding.

More Less

About us

Company details

NeoMedLight develops innovative medical devices designed for phototherapy. The company is the owner of a unique and proprietary technology: the emission of light through woven optic fibers, the Fabric of Light (Lightex®). This technology was originally developed by Brochier Technologies (www.brochiertechnologies.com) with which NeoMedLight shares the overall ownership. NeoMedLight has the exclusivity in healthcare.

The company has initially conceived and developed a fiber-optic phototherapy device to treat neonatal jaundice; Further therapeutic indications that would benefit from the Fabric of Light may include mucositis, dermatitis, wound healing/tissue regeneration, as well as pain management.

The objective of NeoMedLight® is to bring the innovation to all therapeutic fields in which it will benefit patients and healthcare providers.

NeoMedLight is certified ISO 13485

More Less